LABLYTICA.

We offer bioanalytical services in biological matrices such as blood, tissue samples and urine. The research and development activities are carried out at our facility in Uppsala, Sweden. We are fully compliant with OECD GLP and relevant regulatory guidelines from EMA and FDA.

We Know Bioanalysis

Our team consists of 8 dedicated analytical chemists who aim for fast and high-quality delivery of exactly what you need. We specialise in bioanalysis in the preclinical and clinical stage of your drug development.

Lablytica is part of the Swedish OECD GLP program. The last OECD GLP inspection of Lablytica was performed in November 2020.

Lablytica is regularly inspected by SWEDAC, the regulatory body performing OECD GLP inspection of laboratories in Sweden.

Lablytica is represented in the core group of the European Bioanalysis Forum (EBF).